If you are interested in familial leukemia and RNA biology, have a look at our open postdoctoral position. Join us at @QMBCI in this project funded by the @CR_UK Early detection & diagnosis award! ⬇️⬇️⬇️
Check out our paper just out in BJH studying the phenotypic effects of germline ERCC6L2 loss in the haematopoietic compartment & bone marrow microenvironment! @kevin_rouault @fitzgi02 #familialAML https://t.co/Fm5bwwKPPm
Our paper looking at the acquired mutations in a cohort of families with inherited myeloid malignancies is now out in @LeukemiaJnl ! @fitzgi02 @anariomachin@CsabaBdr1@krizsanszilvi https://t.co/3YLKdU4mCk
It is great to see more of the Fitzgibbon lab at Barts Cancer Institute active on #AML World Awareness Day. Thank you for your dedication to AML, Dr. Hannah Armes! ❤️🖤 #KnowAML@hanarmes @Fitzgi02 @QMBCI#leusm#hematology
Congrats @anariomachin and @fitzgi02 👏 Such important work reporting the complex genetic landscape of familial #AML in the largest cohort of families to date. Huge thanks to @bloodwise_uk for funding! @NatureComms
https://t.co/1XET8ENZjS